Drug Shortage Report for QUETIAPINE XR
Report ID | 121787 |
Drug Identification Number | 02417383 |
Brand name | QUETIAPINE XR |
Common or Proper name | QUETIAPINE XR |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-08-31 |
Actual start date | |
Estimated end date | 2020-09-25 |
Actual end date | 2020-09-30 |
Shortage status | Resolved |
Updated date | 2020-10-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-10-09 | French | Compare |
v4 | 2020-10-09 | English | Compare |
v3 | 2020-09-01 | English | Compare |
v2 | 2020-08-05 | French | Compare |
v1 | 2020-08-05 | English | Compare |
Showing 1 to 5 of 5